| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/10/2002 | WO2002002762A1 Novel lipase |
| 01/10/2002 | WO2002002761A2 57658, a human uridine kinase and uses thereof |
| 01/10/2002 | WO2002002757A2 Adenylyl and guanylyl cyclases |
| 01/10/2002 | WO2002002754A2 Regulation of human alpha-hydroxysteroid dehydrogenase-like enzyme |
| 01/10/2002 | WO2002002753A2 Nucleotide sequence encoding benzaldehyde lyase and method for the stereoselective synthesis of 2-hydroxy ketones |
| 01/10/2002 | WO2002002751A2 Alteration of cell membrane |
| 01/10/2002 | WO2002002749A1 Transformed yeast for constructing combinatorial protein library |
| 01/10/2002 | WO2002002746A2 Coiled-coil mediated heterodimerization functional interaction trap |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002741A2 Methods for genetic interpretation and prediction of phenotype |
| 01/10/2002 | WO2002002739A2 Ubiquitin ligase |
| 01/10/2002 | WO2002002738A2 Host cells containing multiple integrating vectors |
| 01/10/2002 | WO2002002737A2 High-throughput method for examining the effects of membrane-impermeable compounds that contain no gene |
| 01/10/2002 | WO2002002736A1 Reaction vessel, reaction device and temperature control method for reaction liquid |
| 01/10/2002 | WO2002002641A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | WO2002002640A2 Antibodies to human mcp-1 |
| 01/10/2002 | WO2002002639A2 Human ion channels |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | WO2002002637A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/10/2002 | WO2002002636A2 Membrane associated protein zupari |
| 01/10/2002 | WO2002002635A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
| 01/10/2002 | WO2002002627A2 Interferon-like protein zcyto21 |
| 01/10/2002 | WO2002002626A2 Novel secreted proteins |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
| 01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | WO2002002621A2 Mammalian secreted proteins |
| 01/10/2002 | WO2002002618A1 A NOVEL POLYPEPTIDE - NADH DEHYDROGENASE 51 Kd SUBUNIT 10 AND A POLYNUCLEOTIDE ENCODING THE SAME |
| 01/10/2002 | WO2002002617A1 A novel polypeptide - human beta adducin 10 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002616A1 A novel polypeptide-gamma-cop13 and a polynucleotide encoding thesame |
| 01/10/2002 | WO2002002615A1 A novel polypeptide - cytochrome b5-9.57 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002614A1 A novel polypeptide - human cytochrome c domain containing-tnfr/ngfr protein 14 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002613A1 A novel polypeptide - human oxysterol-binding protein 38.72 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002612A1 A novel polypeptide human - glutamate receptor interacting protein 11.55 and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002611A1 A novel polypeptide-ribosomal protein l22 and speract repeat domain 12, and a polynucleotide encoding the same |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002609A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | WO2002002608A2 NEW SODIUM CHANNEL (rNaV1.5a) AND USE THEREOF |
| 01/10/2002 | WO2002002606A2 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | WO2002002605A2 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/10/2002 | WO2002002604A2 Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002602A2 Slgp protein and nucleic acid molecules and uses therefor |
| 01/10/2002 | WO2002002600A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR27, AND USES THEROF |
| 01/10/2002 | WO2002002599A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF |
| 01/10/2002 | WO2002002598A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR18, AND USES THEROF |
| 01/10/2002 | WO2002002597A2 Peptide extended glycosylated polypeptides |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002584A1 Base analogues |
| 01/10/2002 | WO2002002227A2 Devices and methods for carrying out chemical reactions using photogenerated reagents |
| 01/10/2002 | WO2002002148A2 Dual recombinant gene therapy compositions and methods of use |
| 01/10/2002 | WO2002002147A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | WO2002002143A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 01/10/2002 | WO2002002142A1 Papillomavirus vaccine |
| 01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | WO2002002055A2 Antifungal compounds and methods of use |
| 01/10/2002 | WO2002002054A2 Methods and compositions for the diagnosis of schizophrenia |
| 01/10/2002 | WO2002002053A2 Anticancer transgenic tomato |
| 01/10/2002 | WO2002002011A1 Dna encoding human serine protease d-g |
| 01/10/2002 | WO2002001953A1 Methods to screen for antibiotic agents and their use in treatment of opportunistic infections |
| 01/10/2002 | WO2002001950A2 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | WO2002001949A2 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof |
| 01/10/2002 | WO2001094636A8 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 01/10/2002 | WO2001085973A9 Antisense type gene trap vector |
| 01/10/2002 | WO2001075084A3 Coffee mannanase |
| 01/10/2002 | WO2001070813A3 REGULATION OF HUMAN GluR5-LIKE RECEPTOR |
| 01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 01/10/2002 | WO2001070175A3 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/10/2002 | WO2001059139A3 Ozone and/or pathogen-inducible gene expression in plants |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001055362A3 Hybrid adeno-retroviral vector for the transfection of cells |
| 01/10/2002 | WO2001055307A3 Nucleic acids, proteins, and antibodies |
| 01/10/2002 | WO2001055298A3 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins |
| 01/10/2002 | WO2001055180A3 Gene cluster for everninomicin biosynthesis |
| 01/10/2002 | WO2001051651A3 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 01/10/2002 | WO2001049848A3 Nucleic acids and polypeptides of drosophila melanogaster snf sodium- neurotransmitter symporter family cell surface receptors and methods of use |
| 01/10/2002 | WO2001048483A3 Method for screening of appetite control agents |
| 01/10/2002 | WO2001048145A3 High affinity tcr proteins and methods |
| 01/10/2002 | WO2001046417A3 Human membrane proteins and polynucleotides encoding the same having homology to cd20 proteins and ige receptors |
| 01/10/2002 | WO2001046398A3 Aspartyl proteases |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001045548A3 Surgical needle with weeping tip and method of use |
| 01/10/2002 | WO2001045495A3 Potassium channel stress-related proteins and methods of use in plants |
| 01/10/2002 | WO2001044480A3 Enzymes and genes used for producing vanillin |
| 01/10/2002 | WO2001044457A3 Dna constructs for expression of heterologous polypeptides in plants |
| 01/10/2002 | WO2001044455A3 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 01/10/2002 | WO2001042466A3 Zvwf1: a member of the von willebrand factor type a domain superfamily |
| 01/10/2002 | WO2001042444A3 Methods for expression of genes in primates |
| 01/10/2002 | WO2001042437A3 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 01/10/2002 | WO2001042422A3 Acyl glucosaminyl inositol amidase family and methods of use |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001038485A3 NEMATODE-UPREGULATED PEROXIDASE GENE AND PROMOTER FROM NEMATODE-RESISTANT MAIZE LINE Mp307 |
| 01/10/2002 | WO2001038358A3 Hbv/hcv virus-like particle |
| 01/10/2002 | WO2001036625A3 ANTISENSE OLIGONUCLEOTIDE SEQUENCES DERIVED FROM groEL AND groES AS INHIBITORS MICROORGANISMS |
| 01/10/2002 | WO2001036621A3 Down-regulation and silencing of allergen genes in transgenic peanut seeds |